











Bull & Lifshitz, LLP Announces Investigation of the Acquisition of Hughes Communications, Inc.
Published in Science and Technology on Wednesday, February 23rd 2011 at 8:00 GMT by Market Wire

NEW YORK--([ BUSINESS WIRE ])--Bull & Lifshitz, LLP announces an investigation into possible breaches of fiduciary duty in connection with the proposed acquisition of Hughes Communications, Inc. (NASDAQ: [ HUGH ]) (referred to as "Hughes" or the aCompanya) by EchoStar Corporation (aEchoStara) in a cash transaction valued at approximately $2 billion, including Hughes debt expected to be refinanced in connection with the transaction.
Under the terms of the agreement Hughes' shareholders will receive $60.70 per share without interest. Investment funds affiliated with Apollo Management IV, L.P., who own a majority of Hughes' outstanding stock, have approved the transaction by entering into a written shareholder consent.
Bull & Lifshitz, LLP's investigation is focused on whether the proposed deal provides adequate value to the Companya™s shareholders. If you are a holder of Hughes stock and want to discuss your legal rights, you may e-mail or call Bull & Lifshitz, LLP who will, without obligation or cost to you, attempt to answer your questions.
If you are a shareholder of Hughes and would like more information about our investigation, please contact Peter D. Bull, Esq. by telephone at (866) 313-6222 or by sending an e-mail including your contact information to: [ counsel@nyclasslaw.com ]. All e-mail correspondence should make reference to Hughes.
Bull & Lifshitz, LLP is a New York City-based law firm with significant experience representing investors in merger-related shareholder class actions, shareholder derivative actions, and securities fraud class actions. For more information about the firm, please visit our website at [ www.nyclasslaw.com ].
ATTORNEY ADVERTISING. © 2011 Bull & Lifshitz, LLP. The law firm responsible for this advertisement is Bull & Lifshitz, LLP, 18 East 41st Street, New York, New York 10017, (212) 213-6222. Prior results do not guarantee or predict a similar outcome with respect to any future matter.